Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung.

Kazuya TakamochiHiroko OhmiyaMasayoshi ItohKaoru MogushiTsuyoshi SaitoKieko HaraKeiko MitaniYasushi KogoYasunari YamanakaJun KawaiYoshihide HayashizakiShiaki OhKenji SuzukiHideya Kawaji

Published in: BMC cancer (2016)

We identified two genes, SPATS2 and ST6GALNAC1, as novel complemental biomarkers discriminating SCC and AD. These findings will contribute to a more accurate diagnosis of NSCLC, which is crucial for precision medicine for lung cancer.

Keyphrases

squamous cell carcinoma
small cell lung cancer
high resolution
locally advanced
genome wide
advanced non small cell lung cancer
lymph node metastasis
radiation therapy
bioinformatics analysis
mass spectrometry
epidermal growth factor receptor
tyrosine kinase
brain metastases